NEW DELHI: Sun Pharmaceutical Industries today said it has completed the process of selling two divisions of erstwhile Ranbaxy Laboratories to Strides Shasun for Rs 165 crore. All the necessary formalities for closure of the said transaction have been ... Economic Times, 1 week ago
Sun completes sale of 2 Ranbaxy divisions to Strides - Business Standard, 1 week ago
Strides Shasun gains on receiving CCI nod for acquisition of two CNS division of Ranbaxy - Finalaya.com, 2 weeks ago
1 images for "ranbaxy industries"
Sun Pharmaceutical Industries ' third quarter profit is seen rising 4.4 percent sequentially to Rs 1,157.71 crore and revenue climbing 1.7 percent to Rs 6,955.44 crore, according to analysts polled by CNBC-TV18. Operating profit (earnings before ...Moneycontrol.com, 16 hours ago
And that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global price The Hyderabad-based Bharat Biotech might be the first to come out with a vaccine for the Zika virus if ...Times of India, 4 days ago FDA Warns Sun Pharmaceutical of Quality Problems Peoples Pharmacy, 1 month ago Sun set in 2015: Issues may haunt Sun Pharma in 2016 too India Infoline, 1 month ago US issues new reprimand to Sun Pharma American Journal of Transportation On-Line, 1 month ago
MUMBAI: The Mumbai Industrial Court has rejected a petition filed by the representatives of workers' union of Sun Pharmaceutical Industries seeking a stay on transfer of dozens of medical representatives who were previously on the rolls of Ranbaxy.Economic Times, 2 days ago Mumbai Court rejects union’s claim against Sun Pharmaceutical Industries Economic Times, 2 days ago
1,800 companies legal spend up 18% to $3.5bn - RIL alone billed Rs 1,200 cr, Ranbaxy doubled costs to Rs 850 cr: ET
The Economic Times research arm, the ET Intelligence Group, surveying more than 1,800 listed companies, has revealed that their legal spend was Rs 21,906 crore ($3.5bn) in the 2013-14 financial year, an increase of more than 17.5 per cent on last ...Legally India, 2 days ago
MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country's largest drug maker ...Economic Times, 2 weeks ago
Thanks to some hectic buying in a few front line stocks, including heavyweights Reliance Industries, Infosys and HDFC, the market has moved up smartly this morning, after a positive but somewhat cautious start. The Sensex is now up 204 points or ...Sify, 1 week ago
SENSEX 24559.98 90.41 0.37% NIFTY 7455.45 30.80 0.41% Industries: Banks & Finance, Engineering, Medical/Healthcare, Power, Metal and Mining, Telecom Company Jindal Stainless (Hisar) Ltd , Stone India Ltd , Firstsource ...Finalaya.com, 2 weeks ago
Six years ago, Dilip Shanghvi, the promoter and Managing Director of Sun Pharmaceutical Industries, was clear and confident when asked two questions that were key to the company's future - Is it risky to over-depend on the US market? And, is it ...Business Today India, 3 weeks ago Sun's Eclipse Yahoo! India, 4 weeks ago
SINGAPORE --Shares of Sun Pharmaceutical Industries rose on Tuesday in the Indian stock market after the major manufacturer of generic drugs said it will sell off its U.S. plant. The stockedged up0.66% to close at 773.70 rupees ($11.58), having ...Nikkei Asian Review, 1 month ago Sun Pharma stocks rise nearly 2% after its subsidiary divests stake in US unit DNA, 1 month ago Sun Pharma shares gain 2% as subsidiary divests US unit Moneycontrol.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!